Avista Healthcare Partners and Damier Group to acquire Sanotact Group
Headquartered in Münster, the VMS company combines full-service CDMO capabilities with branded supplements and serves drugstore and distribution customers across 80 international markets.
Takeaways
- Sanotact Group is a German vitamins, minerals, and supplements platform offering CDMO and branded products.
- Avista Healthcare Partners and Damier Group is acquiring Sanotact Group with backing from Avista Healthcare Partners.
- The target serves Consumer health, vitamins, minerals, and supplements, drugstore distribution across Germany.
A German consumer-health asset with CDMO and branded vitamins, minerals and supplements operations, sanotact Group GmbH is under a definitive agreement to be acquired by Avista Healthcare Partners and Damier Group.
Headquartered in Münster, sanotact develops, manufactures and commercializes VMS products for drugstore and distribution customers across 80 international markets.
The company combines a full-service CDMO business across major VMS dosage forms with a branded portfolio that includes sanotact®.
Terms were not disclosed.
FLOTTE Beteiligungen GmbH, an existing shareholder, will reinvest alongside the new shareholders, and the transaction remains subject to regulatory approvals.
Avista Healthcare Partners said the investment is its ninth platform investment in consumer healthcare and continues its partnership with Damier Group.
Alantra advised FLOTTE on M&A, with CMS as legal counsel; White & Case advised Avista Healthcare Partners and Damier Group.
Get tomorrow morning's tape in your inbox.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up before the workday starts.